Heart Failure

View the latest content related to this topic

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes.

Michael O'Riordan

March 21, 2025

Slides

See all

Presentation ACC 2025

Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study

Presenter: Roland R. Van Kimmenade

March 30, 2025

Presentation ACC 2025

Dapagliflozin after Transcatheter Aortic Valve Implantation

Presenter: Sergio Raposeiras-Roubin

March 29, 2025

Presentation THT 2025

How Helpful Can EFIC Be in the US?

Presenter: Graham Nichol

February 13, 2025

Presentation THT 2025

Continuous Molecular Monitoring for Precision Heart Failure Care

Presenter: Alex Yoshikawa

February 13, 2025

Presentation THT 2025

What Are the Major Challenges?

Presenter: David E. Kandzari

February 13, 2025

News

See all

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

By Caitlin E. Cox

March 30, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

By Michael O'Riordan

March 26, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

By L.A. McKeown

March 21, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

By Michael O'Riordan

March 21, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

By Caitlin E. Cox

March 21, 2025

AHA 2024

November 16

November 18, 2024

TCT 2024

October 27

October 30, 2024

ESC Congress 2024

August 30

September 02, 2024

Videos on This Topic

See all

Advertisement

Heart Failure

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Slides

Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study

Dapagliflozin after Transcatheter Aortic Valve Implantation

How Helpful Can EFIC Be in the US?

Continuous Molecular Monitoring for Precision Heart Failure Care

What Are the Major Challenges?

News

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

What’s Going to Be Hot at ACC 2025?

March 2025 Dispatch for the CV Team

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

More on This Topic

Conference Coverage

AHA 2024

TCT 2024

ESC Congress 2024

Videos on This Topic

Advertisement

Heart Failure

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content